Recombinant Human Olfactory Receptor 8U8 (OR8U8) is a class A G protein-coupled receptor (GPCR) belonging to the olfactory receptor superfamily, which mediates odorant detection and signal transduction in humans . Encoded by the OR8U8 gene (HGNC:27538), this receptor is part of the largest multigene family in vertebrates, with over 400 functional members in humans . OR8U8 is annotated under UniProt accession P0C7N1 and classified as a seven-transmembrane protein with ligand-binding specificity influenced by structural motifs . While its precise physiological role remains under investigation, OR88U shares conserved mechanisms with other olfactory receptors, including G protein-mediated signaling cascades and ion channel modulation .
| Feature | Sequence Segment |
|---|---|
| N-terminal region | MAHINCTQATEFILVGLTDHQELKMPLFVLFLSIYLFTVVGNLGLILLIRADTSLNT |
| Transmembrane domain 3 | CYSSVITPKMLGNFLYKQNVISFDACATQLGCFLTFMVSESLLL |
| C-terminal region | DVKDA LKKVIINRNHAFIFLKLRK |
| Parameter | Details |
|---|---|
| Expression System | E. coli |
| Purity | >90% (SDS-PAGE) |
| Storage | -20°C (short-term); -80°C (long-term) |
| Stability | 6–12 months under recommended conditions |
| Tag | N-terminal 10xHis |
OR8U8 is detectable in biological samples using specialized ELISA kits validated for human tissues .
Immune Modulation: ORs like OR51E2 regulate T-cell activity and cytokine release . OR8U8 may similarly influence immune cell chemotaxis or antigen presentation.
Metabolic Regulation: OR1A1 in hepatocytes modulates lipid metabolism via cAMP-PKA signaling . OR8U8 could interact with endogenous metabolites in non-olfactory tissues.
OR8U8 resides in genomic regions prone to copy-number variations (CNVs), which may contribute to interindividual differences in odor perception or disease susceptibility .
Ligand Specificity: OR8U8’s activating odorants remain unidentified. High-throughput screening using calcium imaging or cAMP assays is needed .
Structural Resolution: No crystallographic data exists for OR8U8. Molecular modeling based on conserved GPCR motifs (e.g., Pfam PF13853) is ongoing .
Pathological Correlations: OR dysfunction is linked to neurodegenerative diseases . OR8U8’s role in such contexts warrants exploration.
HGNC: 27538
OR8U8 is a full-length human olfactory receptor protein consisting of 319 amino acids. The amino acid sequence begins with MAHINCTQATEFILVGLTDHQELKMPLFVLFLSIYLFTVVGNLGLILLIRAD and continues through to the C-terminal sequence ending with RNHAFIFLKLRK . Like other olfactory receptors, OR8U8 is primarily localized to the plasma membrane . This localization is critical for its function, as it needs to interact with odorant molecules in the environment. The receptor contains the characteristic seven-transmembrane domain structure common to G-protein coupled receptors (GPCRs), with extracellular N-terminus and intracellular C-terminus. The transmembrane domains form a pocket where odorant binding occurs, triggering conformational changes that activate downstream signaling pathways.
Recombinant OR8U8 can be successfully expressed in E. coli expression systems . The protein can be produced with an N-terminal His-tag to facilitate purification. The recombinant protein preparation typically results in a product with greater than 90% purity as determined by SDS-PAGE . When expressing OR8U8, it's important to note that membrane proteins like olfactory receptors can often form inclusion bodies in bacterial systems, requiring optimization of expression conditions. Alternative eukaryotic expression systems such as yeast, insect cells, or mammalian cells might provide better folding environments for functional studies, though these weren't specifically mentioned in the provided search results for OR8U8.
Recombinant OR8U8 protein is typically supplied as a lyophilized powder . For storage, the following guidelines are recommended:
Store at -20°C/-80°C upon receipt
Aliquoting is necessary for multiple use to prevent protein degradation
Avoid repeated freeze-thaw cycles as they can compromise protein integrity
For reconstitution:
Centrifuge the vial briefly before opening to bring contents to the bottom
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add 5-50% glycerol (final concentration) for long-term storage at -20°C/-80°C, with 50% being the standard recommendation
The protein is typically stored in a Tris/PBS-based buffer with 6% Trehalose at pH 8.0 .
Recombinant OR8U8 can be used in a variety of basic research applications:
SDS-PAGE analysis to study protein characteristics and quality
Structural studies to understand the binding pocket architecture
Ligand binding assays to identify potential odorants that activate this receptor
Antibody generation for immunohistochemistry studies
In vitro signaling assays to characterize receptor function
Additionally, OR8U8 can be used in broader studies investigating olfactory system function, particularly in understanding how individual receptors contribute to odor detection thresholds . The recombinant protein serves as a valuable tool for researchers aiming to understand the molecular basis of olfaction and the specific role of OR8U8 in this sensory system.
Copy-number variation (CNV) of olfactory receptor genes, including OR8U8, represents a significant source of genetic diversity that may impact olfactory perception among individuals . Research indicates that OR genes are enriched in copy-number variable regions of the genome, with this enrichment likely due to their preponderance in segmentally duplicated regions rather than positive selection .
The functional consequences of OR8U8 CNVs may include:
Altered odor detection thresholds for specific odorants
Variable olfactory discrimination abilities
Potential compensatory mechanisms within the olfactory system
Studies of olfactory receptors suggest that odor detection thresholds are determined by the most sensitive receptor for a given odorant, with no contribution from other highly sensitive receptors . If OR8U8 is the threshold-determining receptor for certain odorants, CNV affecting its expression could directly impact an individual's ability to detect these compounds at low concentrations.
Methodologically, researchers investigating OR8U8 CNV effects should consider:
Using multiplex ligation-dependent probe amplification (MLPA) and PCR to accurately assay copy numbers in human populations
Combining genetic analysis with functional assays such as calcium imaging or electrophysiology
Conducting psychophysical testing to correlate genetic variation with perceptual differences
Employing animal models with genetic modifications to determine causative relationships
Studying the ligand interactions and activation mechanisms of OR8U8 requires sophisticated experimental approaches that address the challenges of working with olfactory receptors. Several methodologies can be employed:
Heterologous Expression Systems:
Expression in HEK293 cells or other mammalian cell lines with appropriate chaperones
Incorporation into nanodiscs or liposomes to maintain native-like membrane environment
Use of specialized vectors that enhance surface expression of olfactory receptors
Ligand Identification:
High-throughput screening of odorant libraries using calcium imaging
Measuring cAMP production via BRET or FRET-based assays
Utilizing the DREAM assay (Deorphanization of Receptors based on Expression Alterations in Messenger RNA levels), which measures the downregulation of receptor mRNA after odorant exposure
Structural Analysis:
Computational modeling based on known GPCR structures
Mutagenesis studies to identify key binding residues
Potential application of cryo-EM for structural determination
Functional Validation:
In vivo studies using gene editing techniques
Electrophysiological recordings from cells expressing OR8U8
Behavioral assays to correlate receptor function with perception
When conducting these experiments, odorants should be carefully diluted and delivered using a flow dilution olfactometer to ensure precise concentration control . For in vitro studies, disposable glass vials should be used to prevent cross-contamination, and odor trials should be interleaved with clean air trials to identify potential contamination issues .
Post-translational modifications (PTMs) play crucial roles in the proper trafficking, localization, and function of olfactory receptors including OR8U8. While the search results don't specifically address PTMs for OR8U8, research on olfactory receptors generally indicates several important modifications:
N-linked Glycosylation:
Occurs at conserved asparagine residues in the N-terminal region and extracellular loops
Critical for proper folding and trafficking to the plasma membrane
May affect ligand recognition and binding affinity
Palmitoylation:
Cysteine residues in the C-terminal region are often palmitoylated
Enhances association with lipid rafts in the plasma membrane
Contributes to signaling complex formation with G proteins
Phosphorylation:
Occurs primarily on serine and threonine residues in intracellular loops and C-terminus
Regulates receptor desensitization and internalization
May be mediated by GRKs (G protein-coupled receptor kinases)
Research methodology to study PTMs of OR8U8 should include:
Mass spectrometry to identify specific modification sites
Site-directed mutagenesis to assess the functional importance of modified residues
Live-cell imaging to track trafficking of fluorescently tagged constructs
Co-immunoprecipitation studies to identify interacting proteins involved in PTM processes
Understanding these modifications is critical as they may explain differences in receptor functionality between heterologous expression systems and native olfactory sensory neurons, and could provide insights into the variability of olfactory perception among individuals.
Functional reconstitution of OR8U8 for in vitro binding studies presents significant challenges due to the hydrophobic nature of this membrane protein. Based on general methodologies for olfactory receptors, the following approaches can be recommended:
Detergent Selection and Solubilization:
Mild detergents such as DDM (n-dodecyl-β-D-maltoside), DMNG (decyl maltose neopentyl glycol), or CHAPS are preferred
Detergent concentration should be optimized to maintain protein stability while effectively solubilizing membranes
Addition of cholesterol or other lipids may enhance stability
Membrane Mimetic Systems:
Nanodiscs composed of phospholipids and membrane scaffold proteins
Liposomes with optimized lipid composition mimicking olfactory cilia membranes
Bicelles or amphipols as alternative membrane mimetics
Buffer Optimization:
Binding Assay Development:
Fluorescence-based assays using environmentally sensitive probes
Surface plasmon resonance (SPR) with immobilized receptor
Isothermal titration calorimetry (ITC) for thermodynamic parameters
Microscale thermophoresis (MST) for measuring interactions in solution
For successful reconstitution, the recombinant OR8U8 should be carefully extracted from expression systems using optimized protocols that maintain the native conformation of the protein. The reconstituted protein should be validated for proper folding using circular dichroism spectroscopy and for functionality using ligand binding assays before proceeding with detailed binding studies.
OR8U8, like other olfactory receptors, functions within a complex network that collectively enables odor perception. Understanding its specific contribution requires consideration of several aspects:
Methodologically, researchers investigating OR8U8's contribution to odor coding should consider:
Optical imaging of glomerular responses using calcium or voltage indicators
Single-cell RNA sequencing to identify co-expression patterns with other genes
Computational modeling of receptor network dynamics
Behavioral assays with genetic manipulations to assess the impact of OR8U8 on specific odor perceptions